NAUT
Nautilus Biotechnology, Inc.
Industry
Biotechnology
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was founded in 2016 and is headquartered in Seattle, Washington.
Loading...
Open
1.95
Mkt cap
251M
Volume
99K
High
2.03
P/E Ratio
-3.57
52-wk high
3.46
Low
1.92
Div yield
N/A
52-wk low
1.88

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.